Understanding the pharmacology of stroke and multiple sclerosis through imaging

Matthews, 2011, Non-invasive imaging in experimental medicine for drug development, Curr Opin Pharmacol, 11, 501, 10.1016/j.coph.2011.04.009 Matthews, 2012, Positron emission tomography molecular imaging for drug development, Br J Clin Pharmacol, 73, 175, 10.1111/j.1365-2125.2011.04085.x Matthews, 2013, Technologies: preclinical imaging for drug development, Drug Discov Today Technol, 10, e343, 10.1016/j.ddtec.2012.04.004 Rha, 2007, The impact of recanalization on ischemic stroke outcome: a meta-analysis, Stroke, 38, 967, 10.1161/01.STR.0000258112.14918.24 Green, 2008, Pharmacological approaches to acute ischaemic stroke: reperfusion certainly, neuroprotection possibly, Br J Pharmacol, 153, S325, 10.1038/sj.bjp.0707594 Adams, 2003, Guidelines for the early management of patients with ischemic stroke: a scientific statement from the Stroke Council of the American Stroke Association, Stroke, 34, 1056, 10.1161/01.STR.0000064841.47697.22 Schriger, 1998, Cranial computed tomography interpretation in acute stroke: physician accuracy in determining eligibility for thrombolytic therapy, JAMA, 279, 1293, 10.1001/jama.279.16.1293 Wardlaw, 1999, Can stroke physicians and neuroradiologists identify signs of early cerebral infarction on CT?, J Neurol Neurosurg Psychiatry, 67, 651, 10.1136/jnnp.67.5.651 Grotta, 1999, Agreement and variability in the interpretation of early CT changes in stroke patients qualifying for intravenous rtPA therapy, Stroke, 30, 1528, 10.1161/01.STR.30.8.1528 Kalafut, 2000, Detection of early CT signs of >1/3 middle cerebral artery infarctions: interrater reliability and sensitivity of CT interpretation by physicians involved in acute stroke care, Stroke, 31, 1667, 10.1161/01.STR.31.7.1667 Barber, 2000, Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy ASPECTS Study Group. Alberta Stroke Programme Early CT Score, Lancet, 355, 1670, 10.1016/S0140-6736(00)02237-6 Hjort, 2005, Ischemic injury detected by diffusion imaging 11minutes after stroke, Ann Neurol, 58, 462, 10.1002/ana.20595 Albach, 2013, Complete early reversal of diffusion-weighted imaging hyperintensities after ischemic stroke is mainly limited to small embolic lesions, Stroke, 44, 1043, 10.1161/STROKEAHA.111.676346 Hacke, 1998, Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II) Second European-Australasian Acute Stroke Study Investigators, Lancet, 352, 1245, 10.1016/S0140-6736(98)08020-9 Vahedi, 2007, Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials, Lancet Neurol, 6, 215, 10.1016/S1474-4422(07)70036-4 Jaramillo, 2006, Predictors for malignant middle cerebral artery infarctions: a postmortem analysis, Neurology, 66, 815, 10.1212/01.wnl.0000203649.60211.0e Saposnik, 2012, The iScore predicts effectiveness of thrombolytic therapy for acute ischemic stroke, Stroke, 43, 1315, 10.1161/STROKEAHA.111.646265 Strbian, 2012, Predicting outcome of IV thrombolysis-treated ischemic stroke patients: the DRAGON score, Neurology, 78, 427, 10.1212/WNL.0b013e318245d2a9 Mazya, 2012, Predicting the risk of symptomatic intracerebral hemorrhage in ischemic stroke treated with intravenous alteplase: safe Implementation of Treatments in Stroke (SITS) symptomatic intracerebral hemorrhage risk score, Stroke, 43, 1524, 10.1161/STROKEAHA.111.644815 Schramm, 2004, Comparison of perfusion computed tomography and computed tomography angiography source images with perfusion-weighted imaging and diffusion-weighted imaging in patients with acute stroke of less than 6hours’ duration, Stroke, 35, 1652, 10.1161/01.STR.0000131271.54098.22 Schaefer, 2008, Quantitative assessment of core/penumbra mismatch in acute stroke: CT and MR perfusion imaging are strongly correlated when sufficient brain volume is imaged, Stroke, 39, 2986, 10.1161/STROKEAHA.107.513358 Wintermark, 2005, Brain perfusion-CT in acute stroke patients, Eur Radiol, 15 Suppl 4, D28, 10.1007/s10406-005-0112-y Alsop, 1996, Reduced transit-time sensitivity in noninvasive magnetic resonance imaging of human cerebral blood flow, J Cereb Blood Flow Metab, 16, 1236, 10.1097/00004647-199611000-00019 Tong, 1998, Correlation of perfusion- and diffusion-weighted MRI with NIHSS score in acute (<6.5hour) ischemic stroke, Neurology, 50, 864, 10.1212/WNL.50.4.864 Barber, 1999, Identification of major ischemic change. Diffusion-weighted imaging versus computed tomography, Stroke, 30, 2059, 10.1161/01.STR.30.10.2059 Lovblad, 1997, Ischemic lesion volumes in acute stroke by diffusion-weighted magnetic resonance imaging correlate with clinical outcome, Ann Neurol, 42, 164, 10.1002/ana.410420206 Barber, 2005, Imaging of the brain in acute ischaemic stroke: comparison of computed tomography and magnetic resonance diffusion-weighted imaging, J Neurol Neurosurg Psychiatry, 76, 1528, 10.1136/jnnp.2004.059261 Hand, 2005, Magnetic resonance brain imaging in patients with acute stroke: feasibility and patient related difficulties, J Neurol Neurosurg Psychiatry, 76, 1525, 10.1136/jnnp.2005.062539 Singer, 2004, Practical limitations of acute stroke MRI due to patient-related problems, Neurology, 62, 1848, 10.1212/01.WNL.0000125320.53244.FA Liebeskind, 2003, Collateral circulation, Stroke, 34, 2279, 10.1161/01.STR.0000086465.41263.06 Liebeskind, 2005, Neuroprotection from the collateral perspective, IDrugs, 8, 222 Heiss, 1992, Progressive derangement of periinfarct viable tissue in ischemic stroke, J Cereb Blood Flow Metab, 12, 193, 10.1038/jcbfm.1992.29 Baron, 1981, Reversal of focal “misery-perfusion syndrome” by extra-intracranial arterial bypass in hemodynamic cerebral ischemia. A case study with 15O positron emission tomography, Stroke, 12, 454, 10.1161/01.STR.12.4.454 Furlan, 1996, Spontaneous neurological recovery after stroke and the fate of the ischemic penumbra, Ann Neurol, 40, 216, 10.1002/ana.410400213 Wegener, 2006, Temporal profile of T2-weighted MRI distinguishes between pannecrosis and selective neuronal death after transient focal cerebral ischemia in the rat, J Cereb Blood Flow Metab, 26, 38, 10.1038/sj.jcbfm.9600166 Baron, 1995, What is the predictive value of increased technetium-99m-HMPAO uptake for brain survival/necrosis in the acute stage of ischemic stroke?, J Nucl Med, 36, 2392 Staroselskaya, 2001, Relationship between magnetic resonance arterial patency and perfusion-diffusion mismatch in acute ischemic stroke and its potential clinical use, Arch Neurol, 58, 1069, 10.1001/archneur.58.7.1069 Moustafa, 2008, Pathophysiology of ischaemic stroke: insights from imaging, and implications for therapy and drug discovery, Br J Pharmacol, 153, S44, 10.1038/sj.bjp.0707530 Lemmens, 2013, Comparison of the response to endovascular reperfusion in relation to site of arterial occlusion, Neurology, 81, 614, 10.1212/WNL.0b013e3182a08f07 Zhang, 1994, Temporal profile of ischemic tissue damage, neutrophil response, and vascular plugging following permanent and transient (2H) middle cerebral artery occlusion in the rat, J Neurol Sci, 125, 3, 10.1016/0022-510X(94)90234-8 Matsuo, 1994, Correlation between myeloperoxidase-quantified neutrophil accumulation and ischemic brain injury in the rat. Effects of neutrophil depletion, Stroke, 25, 1469, 10.1161/01.STR.25.7.1469 Dirnagl, 1999, Pathobiology of ischaemic stroke: an integrated view, Trends Neurosci, 22, 391, 10.1016/S0166-2236(99)01401-0 Danton, 2003, Inflammatory mechanisms after ischemia and stroke, J Neuropathol Exp Neurol, 62, 127, 10.1093/jnen/62.2.127 Liesz, 2011, Inhibition of lymphocyte trafficking shields the brain against deleterious neuroinflammation after stroke, Brain, 134, 704, 10.1093/brain/awr008 Lalancette-Hebert, 2007, Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain, J Neurosci, 27, 2596, 10.1523/JNEUROSCI.5360-06.2007 Oku, 2010, Nuclear neuroimaging in acute and subacute ischemic stroke, Ann Nucl Med, 24, 629, 10.1007/s12149-010-0421-7 Deddens, 2012, Imaging neuroinflammation after stroke: current status of cellular and molecular MRI strategies, Cerebrovasc Dis, 33, 392, 10.1159/000336116 Cramer, 2000, A pilot study of somatotopic mapping after cortical infarct, Stroke, 31, 668, 10.1161/01.STR.31.3.668 Wieloch, 2006, Mechanisms of neural plasticity following brain injury, Curr Opin Neurobiol, 16, 258, 10.1016/j.conb.2006.05.011 Ward, 2004, Functional reorganization of the cerebral motor system after stroke, Curr Opin Neurol, 17, 725, 10.1097/00019052-200412000-00013 Johansen-Berg, 2002, The role of ipsilateral premotor cortex in hand movement after stroke, Proc Natl Acad Sci U S A, 99, 14518, 10.1073/pnas.222536799 Grefkes, 2013, Cortical reorganization after stroke: how much and how functional?, Neuroscientist Swayne, 2008, Stages of motor output reorganization after hemispheric stroke suggested by longitudinal studies of cortical physiology, Cereb Cortex, 18, 1909, 10.1093/cercor/bhm218 Polman, 2008, Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria, Ann Neurol, 69, 292, 10.1002/ana.22366 Harris, 1991, Serial gadolinium-enhanced magnetic resonance imaging scans in patients with early, relapsing-remitting multiple sclerosis: implications for clinical trials and natural history, Ann Neurol, 29, 548, 10.1002/ana.410290515 Rovaris, 2011, Relationship between brain MRI lesion load and short-term disease evolution in non-disabling MS: a large-scale, multicentre study, Mult Scler, 17, 319, 10.1177/1352458510388824 Montalban, 2010, MRI criteria for MS in patients with clinically isolated syndromes, Neurology, 74, 427, 10.1212/WNL.0b013e3181cec45c Miller, 2012, Clinically isolated syndromes, Lancet Neurol, 11, 157, 10.1016/S1474-4422(11)70274-5 Sormani, 2011, Surrogate endpoints for EDSS worsening in multiple sclerosis. A meta-analytic approach, Neurology, 75, 302, 10.1212/WNL.0b013e3181ea15aa Sormani, 2011, Combined MRI lesions and relapses as a surrogate for disability in multiple sclerosis, Neurology, 77, 1684, 10.1212/WNL.0b013e31823648b9 Sormani, 2013, MRI lesions as a surrogate for relapses in multiple sclerosis: a meta-analysis of randomised trials, Lancet Neurol, 12, 669, 10.1016/S1474-4422(13)70103-0 Giacomini, 2009, Defining multiple sclerosis treatment response with magnetic resonance imaging: how much activity is too much?, Arch Neurol, 66, 19, 10.1001/archneurol.2008.529 Chiu, 2009, Heterogeneity in response to interferon beta in patients with multiple sclerosis: a 3-year monthly imaging study, Arch Neurol, 66, 39, 10.1001/archneur.66.1.noc80047 Bermel, 2013, Predictors of long-term outcome in multiple sclerosis patients treated with interferon beta, Ann Neurol, 73, 95, 10.1002/ana.23758 Barkhof, 2012, MRI monitoring of immunomodulation in relapse-onset multiple sclerosis trials, Nat Rev Neurol, 8, 13, 10.1038/nrneurol.2011.190 Selmaj, 2013, Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 study, Lancet Neurol, 12, 756, 10.1016/S1474-4422(13)70102-9 Lee, 1998, Defining multiple sclerosis disease activity using MRI T2-weighted difference imaging, Brain, 121, 2095, 10.1093/brain/121.11.2095 Moraal, 2010, Long-interval T2-weighted subtraction magnetic resonance imaging: a powerful new outcome measure in multiple sclerosis trials, Ann Neurol, 67, 667 Calabrese, 2012, Cortical lesion load associates with progression of disability in multiple sclerosis, Brain, 135, 2952, 10.1093/brain/aws246 Calabrese, 2013, Low degree of cortical pathology is associated with benign course of multiple sclerosis, Mult Scler, 19, 904, 10.1177/1352458512463767 Rinaldi, 2012, Natalizumab strongly suppresses cortical pathology in relapsing-remitting multiple sclerosis, Mult Scler, 18, 1760, 10.1177/1352458512447704 Seewann, 2012, Postmortem verification of MS cortical lesion detection with 3D DIR, Neurology, 78, 302, 10.1212/WNL.0b013e31824528a0 Sethi, 2012, Improved detection of cortical MS lesions with phase-sensitive inversion recovery MRI, J Neurol Neurosurg Psychiatry, 83, 877, 10.1136/jnnp-2012-303023 Kilsdonk, 2013, Multicontrast MR imaging at 7T in multiple sclerosis: highest lesion detection in cortical gray matter with 3D-FLAIR, AJNR Am J Neuroradiol, 34, 791, 10.3174/ajnr.A3289 Lassmann, 2012, Progressive multiple sclerosis: pathology and pathogenesis, Nat Rev Neurol, 8, 647, 10.1038/nrneurol.2012.168 Banati, 2000, The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity, Brain, 123, 2321, 10.1093/brain/123.11.2321 Oh, 2011, Translocator protein PET imaging for glial activation in multiple sclerosis, J Neuroimmune Pharmacol, 6, 354, 10.1007/s11481-010-9243-6 Owen, 2011, Mixed-affinity binding in humans with 18-kDa translocator protein ligands, J Nucl Med, 52, 24, 10.2967/jnumed.110.079459 Owen, 2012, An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28, J Cereb Blood Flow Metab, 32, 1, 10.1038/jcbfm.2011.147 Guo, 2013, Quantification of 18F-PBR111 PET for TSPO imaging in humans, J Nucl Med, 54, 1915, 10.2967/jnumed.113.121020 Colasanti, 2013, [18F]PBR111 binding is increased in lesional and peri-lesional white matter of MS patients, J Nucl Med Meeting Abstracts, 54, 82 Huang, 2012, Current status of myelin replacement therapies in multiple sclerosis, Prog Brain Res, 201, 219, 10.1016/B978-0-444-59544-7.00011-1 Skihar, 2009, Promoting oligodendrogenesis and myelin repair using the multiple sclerosis medication glatiramer acetate, Proc Natl Acad Sci U S A, 106, 17992, 10.1073/pnas.0909607106 Miron, 2010, Fingolimod (FTY720) enhances remyelination following demyelination of organotypic cerebellar slices, Am J Pathol, 176, 2682, 10.2353/ajpath.2010.091234 Horsfield, 2005, Magnetization transfer imaging in multiple sclerosis, J Neuroimaging, 15, 58S, 10.1177/1051228405282242 Chen, 2008, Magnetization transfer ratio evolution with demyelination and remyelination in multiple sclerosis lesions, Ann Neurol, 63, 254, 10.1002/ana.21302 Meyers, 2013, Multicenter measurements of myelin water fraction and geometric mean T: intra- and intersite reproducibility, J Magn Reson Imaging, 10.1002/jmri.24106 Paling, 2012, Reduced R2′ in multiple sclerosis normal appearing white matter and lesions may reflect decreased myelin and iron content, J Neurol Neurosurg Psychiatry, 83, 785, 10.1136/jnnp-2012-302541 Stankoff, 2011, Imaging central nervous system myelin by positron emission tomography in multiple sclerosis using [methyl-(1)(1)C]-2-(4′-methylaminophenyl)-6-hydroxybenzothiazole, Ann Neurol, 69, 673, 10.1002/ana.22320 Wu, 2013, Longitudinal PET imaging for monitoring myelin repair in the spinal cord, Ann Neurol, 10.1002/ana.23965 Chen, 2004, Relating neocortical pathology to disability progression in multiple sclerosis using MRI, NeuroImage, 23, 1168, 10.1016/j.neuroimage.2004.07.046 Cifelli, 2002, Thalamic neurodegeneration in multiple sclerosis, Ann Neurol, 52, 650, 10.1002/ana.10326 Shiee, 2012, Revisiting brain atrophy and its relationship to disability in multiple sclerosis, PLoS ONE, 7, e37049, 10.1371/journal.pone.0037049 Fisher, 2002, Eight-year follow-up study of brain atrophy in patients with MS, Neurology, 59, 1412, 10.1212/01.WNL.0000036271.49066.06 Fisher, 2008, Gray matter atrophy in multiple sclerosis: a longitudinal study, Ann Neurol, 64, 255, 10.1002/ana.21436 De Stefano, 2010, Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes, Neurology, 74, 1868, 10.1212/WNL.0b013e3181e24136 Barkhof, 2009, Imaging outcomes for neuroprotection and repair in multiple sclerosis trials, Nat Rev Neurol, 5, 256, 10.1038/nrneurol.2009.41 van den Elskamp, 2010, Cerebral atrophy as outcome measure in short-term phase 2 clinical trials in multiple sclerosis, Neuroradiology, 52, 875, 10.1007/s00234-009-0645-1 Vrenken, 2012, Recommendations to improve imaging and analysis of brain lesion load and atrophy in longitudinal studies of multiple sclerosis, J Neurol Lukas, 2013, Relevance of spinal cord abnormalities to clinical disability in multiple sclerosis: MR imaging findings in a large cohort of patients, Radiology, 10.1148/radiol.13122566 Kearney, 2013, Magnetic resonance imaging correlates of physical disability in relapse onset multiple sclerosis of long disease duration, Mult Scler Gordon-Lipkin, 2007, Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis, Neurology, 69, 1603, 10.1212/01.wnl.0000295995.46586.ae Saidha, 2013, Relationships between retinal axonal and neuronal measures and global central nervous system pathology in multiple sclerosis, JAMA Neurol, 70, 34, 10.1001/jamaneurol.2013.573 Henderson, 2011, Early factors associated with axonal loss after optic neuritis, Ann Neurol, 70, 955, 10.1002/ana.22554 Craner, 2004, Molecular changes in neurons in multiple sclerosis: altered axonal expression of Nav1.2 and Nav1.6 sodium channels and Na+/Ca2+ exchanger, Proc Natl Acad Sci U S A, 101, 8168, 10.1073/pnas.0402765101 Inglese, 2010, Brain tissue sodium concentration in multiple sclerosis: a sodium imaging study at 3tesla, Brain, 133, 847, 10.1093/brain/awp334 Zaaraoui, 2012, Distribution of brain sodium accumulation correlates with disability in multiple sclerosis: a cross-sectional 23Na MR imaging study, Radiology, 264, 859, 10.1148/radiol.12112680 Maarouf, 2013, Topography of brain sodium accumulation in progressive multiple sclerosis, Magma Paling, 2013, Sodium accumulation is associated with disability and a progressive course in multiple sclerosis, Brain, 136, 2305, 10.1093/brain/awt149